Efficacy and toxicity of cladribine for the treatment of refractory acute myeloid leukemia: a meta-analysis
Anqi Zhou, Qi Han, Huihui Song, Jie Zi, Jinlong Ma, Zheng GeDepartment of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University, Nanjing 210009, People’s Republic of ChinaPurpose: To investigate the overall efficacy and toxicity of cladribine and c...
Saved in:
Main Authors: | Zhou A (Author), Han Q (Author), Song H (Author), Zi J (Author), Ma J (Author), Ge Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia
by: Yuan-Yuan Shi, et al.
Published: (2023) -
Toxicity profile and outcomes of salvage chemotherapy regimens in children and adolescents with relapsed/refractory acute myeloid leukemia
by: Maharshi Trivedi, et al.
Published: (2024) -
Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
by: Romeo-Gabriel Mihaila
Published: (2015) -
Quizartinib (AC220): a promising option for acute myeloid leukemia
by: Zhou F, et al.
Published: (2019) -
Disseminated fusariosis with ecthyma gangrenosum-like lesions in a refractory acute myeloid leukemia patient
by: Masoud Mardani, et al.
Published: (2019)